Viewing Study NCT03944460


Ignite Creation Date: 2025-12-25 @ 2:04 AM
Ignite Modification Date: 2026-02-18 @ 12:56 AM
Study NCT ID: NCT03944460
Status: COMPLETED
Last Update Posted: 2019-05-09
First Post: 2019-04-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SAD Phase I Study (First-in-human) to Investigate Contraloid Acetate
Sponsor: Prof. Dr. Dieter Willbold
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: EUDRA-CT: 2017-000396-93
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None OTHER View
None UNKNOWN View